Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAVNEOS for Otolaryngologic Manifestations of Granulomatosis With Polyangiitis
NCT07176546Phase 3Recruiting
- Start
- May 2026
- Primary completion
- Jul 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of avacopan in granulomatosis with polyangiitis (GPA). Started May 2026; status: recruiting.
02
Drugs
avacopan
03
Conditions
granulomatosis with polyangiitis (GPA)
Beyond the preview
Go deeper on NCT07176546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07176546.